63629-4023 Ondansetron Hydrochloride

Product NDC:

63629-4023

Brand Name:

Ondansetron Hydrochloride

Generic Name:

Ondansetron Hydrochloride

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: Ondansetron Hydrochloride

Strength: 4.0

Unit: mg/1

Packages:

Code: 63629-4023-00

Description: 60 TABLET, FILM COATED in 1 BOTTLE (63629-4023-0)

Effective Date: March 18, 2013

Discontinued:

Code: 63629-4023-01

Description: 10 TABLET, FILM COATED in 1 BOTTLE (63629-4023-1)

Effective Date: June 15, 2009

Discontinued:

Code: 63629-4023-02

Description: 3 TABLET, FILM COATED in 1 BOTTLE (63629-4023-2)

Effective Date: March 18, 2010

Discontinued:

Code: 63629-4023-03

Description: 30 TABLET, FILM COATED in 1 BOTTLE (63629-4023-3)

Effective Date: Oct. 28, 2009

Discontinued:

Code: 63629-4023-04

Description: 15 TABLET, FILM COATED in 1 BOTTLE (63629-4023-4)

Effective Date: Nov. 12, 2009

Discontinued:

Code: 63629-4023-05

Description: 6 TABLET, FILM COATED in 1 BOTTLE (63629-4023-5)

Effective Date: Aug. 27, 2010

Discontinued:

Code: 63629-4023-06

Description: 4 TABLET, FILM COATED in 1 BOTTLE (63629-4023-6)

Effective Date: March 11, 2014

Discontinued:

Code: 63629-4023-07

Description: 90 TABLET, FILM COATED in 1 BOTTLE (63629-4023-7)

Effective Date: April 12, 2013

Discontinued:

Code: 63629-4023-08

Description: 12 TABLET, FILM COATED in 1 BOTTLE (63629-4023-8)

Effective Date: Aug. 25, 2011

Discontinued:

Code: 63629-4023-09

Description: 20 TABLET, FILM COATED in 1 BOTTLE (63629-4023-9)

Effective Date: May 20, 2011

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC